Envestnet Asset Management Inc. Boosts Stock Position in Huron Consulting Group Inc. (NASDAQ:HURN)

Envestnet Asset Management Inc. raised its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN – Get Rating) by 1.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,221 shares of the business services provider’s stock after buying an additional 251 shares during the period. Envestnet Asset Management Inc. owned about 0.07% of Huron Consulting Group worth $1,032,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of HURN. Vanguard Group Inc. boosted its position in Huron Consulting Group by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 2,041,969 shares of the business services provider’s stock valued at $93,542,000 after buying an additional 21,752 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Huron Consulting Group by 57.1% during the first quarter. Dimensional Fund Advisors LP now owns 1,621,725 shares of the business services provider’s stock valued at $74,291,000 after buying an additional 589,297 shares during the period. Wellington Management Group LLP increased its position in shares of Huron Consulting Group by 6.1% during the first quarter. Wellington Management Group LLP now owns 1,621,460 shares of the business services provider’s stock valued at $74,279,000 after buying an additional 92,846 shares during the period. Invesco Ltd. lifted its stake in shares of Huron Consulting Group by 9.0% in the 1st quarter. Invesco Ltd. now owns 435,172 shares of the business services provider’s stock valued at $19,935,000 after purchasing an additional 35,836 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Huron Consulting Group by 4.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 234,327 shares of the business services provider’s stock worth $10,735,000 after acquiring an additional 10,123 shares in the last quarter. 93.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. StockNews.com initiated coverage on Huron Consulting Group in a research report on Thursday, May 18th. They issued a “hold” rating on the stock. Barrington Research lifted their price objective on Huron Consulting Group from $89.00 to $105.00 and gave the company an “outperform” rating in a research note on Friday, March 3rd. Benchmark increased their price objective on shares of Huron Consulting Group from $95.00 to $100.00 in a research report on Wednesday, May 3rd. Finally, Truist Financial increased their price objective on shares of Huron Consulting Group from $85.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, March 2nd.

Insider Buying and Selling at Huron Consulting Group

In other Huron Consulting Group news, Director H Eugene Lockhart sold 952 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of $80.06, for a total value of $76,217.12. Following the completion of the sale, the director now owns 35,955 shares in the company, valued at approximately $2,878,557.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, CEO C. Mark Hussey bought 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 5th. The shares were bought at an average cost of $72.48 per share, for a total transaction of $144,960.00. Following the completion of the transaction, the chief executive officer now owns 110,286 shares of the company’s stock, valued at $7,993,529.28. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director H Eugene Lockhart sold 952 shares of Huron Consulting Group stock in a transaction on Monday, March 6th. The stock was sold at an average price of $80.06, for a total transaction of $76,217.12. Following the transaction, the director now directly owns 35,955 shares of the company’s stock, valued at $2,878,557.30. The disclosure for this sale can be found here. Insiders own 2.02% of the company’s stock.

Huron Consulting Group Price Performance

NASDAQ HURN opened at $80.62 on Friday. Huron Consulting Group Inc. has a 52 week low of $56.38 and a 52 week high of $87.44. The firm has a market capitalization of $1.55 billion, a P/E ratio of 26.43 and a beta of 0.56. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.85. The company has a 50-day moving average price of $80.39 and a 200-day moving average price of $75.50.

Huron Consulting Group (NASDAQ:HURN – Get Rating) last issued its quarterly earnings results on Tuesday, May 2nd. The business services provider reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.20. The business had revenue of $317.90 million for the quarter, compared to analysts’ expectations of $299.65 million. Huron Consulting Group had a net margin of 5.09% and a return on equity of 14.08%. The company’s revenue was up 22.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.49 EPS. Equities research analysts anticipate that Huron Consulting Group Inc. will post 4.13 earnings per share for the current year.

About Huron Consulting Group

(Get Rating)

Huron Consulting Group, Inc engages in the provision of technology, data, and analytics solutions. It operates through the following segments: Healthcare, Education, and Commercial. The Healthcare segment focuses on serving acute care providers including national and regional health systems, academic health systems, and community health systems, and public, children, and critical access hospitals, and non-acute care providers including physician practices and medical groups, payors, and long-term care or post-acute providers.